MedPath

The Effect of Peripartum Magnesium Sulfate Use on the Occurrence of Postpartum Depression

Recruiting
Conditions
Postpartum Depression
Interventions
Registration Number
NCT05751746
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

This is an observational study that will be conducted on pregnant women under vaginal delivery or cesarean section. The magnesium sulfate will be given to appropriate participants with a protocol that obstetrician are already using in our hospital. After delivery, participants are asked to answer sequential questionnaires to assess postpartum depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
108
Inclusion Criteria
  • Pregnant women who will do delivery.
  • Gestational week >= 30 week
  • Singleton
Exclusion Criteria
  • History of depression

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Magnesium groupMagnesium sulfateIntervention group with participants who get magnesium sulfate administration.
Primary Outcome Measures
NameTimeMethod
postpartum depression6 week after discharge

depression diagnosis using K-EPDS(Korean version of Edinburgh Postnatal Depression Scale) on a scale of 7 to 30 points.

postpartum depression severity6 week after discharge

depression severity using K-EPDS; mild (7\~13 points), moderate (14\~19 points), severe (20\~30 points)

Secondary Outcome Measures
NameTimeMethod
postpartum depression2week after discharge

depression diagnosis using K-EPDS(Korean version of Edinburgh Postnatal Depression Scale) on a scale of 7 to 30 points.

postpartum depression severity2 week after discharge

depression severity using K-EPDS; mild (7\~13 points), moderate (14\~19 points), severe (20\~30 points)

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonguido, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath